DDrare: Database of Drug Development for Rare Diseases

Ubiquinol (DrugBank: Ubiquinol)

3 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
8	Huntington disease	1
17	Multiple system atrophy	1

6. Parkinson disease [ 2,123 clinical trials, 2,046 drugs, (DrugBank: 324 drugs), 183 drug target genes, 198 drug target pathways]

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,123 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03061513 (ClinicalTrials.gov)	February 28, 2012	13/2/2017	Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers	Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers	Parkinson Disease	Drug: Ubiquinol;Dietary Supplement: Placebo	Weill Medical College of Cornell University	NULL	Completed	40 Years	75 Years	All	11	Phase 2	NULL

8. Huntington disease [ 197 clinical trials, 171 drugs, (DrugBank: 54 drugs), 82 drug target genes, 144 drug target pathways]

Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 197 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00980694 (ClinicalTrials.gov)	September 2009	17/9/2009	Bioavailability of Ubiquinol in Huntington Disease	Bioavailability of Ubiquinol in Huntington Disease	Huntington Disease	Dietary Supplement: ubiquinol	University of Rochester	Kaneka Corporation	Completed	18 Years	N/A	Both	6	Phase 1	United States

17. Multiple system atrophy [ 107 clinical trials, 153 drugs, (DrugBank: 48 drugs), 59 drug target genes, 104 drug target pathways]

Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 107 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000010712	2013/05/20	15/05/2013	Ubiquinol for patients with multiple system atrophy		Patients with multiple system atrophy	Patients with administration of ubiquinol	Department of Neurology, the University of Tokyo Hospital	NULL	Complete: follow-up complete	30years-old	80years-old	Male and Female	1	Not selected	Japan